Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05960305 · ClinicalTrials.gov registry record · NA
CSD201204 An Actual Use Study of P12 Electronic Nicotine Delivery System Among U.S. Adult Smokers
A NA study, sponsored by RAI Services Company.
- Completed
- Registry status
- NA
- Development phase
- 1,845
- Enrollment target
NCT05960305 is a NA study that has completed, run by RAI Services Company. The registered enrollment target is 1,845 participants.
The verdict
NCT05960305, a NA study, has completed, sponsored by RAI Services Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,845 participants
- Enrollment target
Study Summary
The purpose of this Actual Use Study (AUS) is to investigate how United States (US) adult tobacco consumers 21 to 60 years of age, inclusive, who are regular smokers (≥5 cigarettes/day on at least 20 of the past 30 days) will use the Cartridge-based ENDS investigational products (Study IP) over a 6-week Actual Use Period (AUP) in their real-life/naturalistic environments. Subjects will be able to choose freely among the Study IP available in one of the three study arms to which they are randomly assigned. The three study arms are organized by Study IP flavor categories: tobacco, menthol, and non-tobacco-non-menthol (NTNM). Subjects will self-report their ad libitum use of the Study IP as well as use of Combustible Cigarettes (CC) and any other tobacco- and nicotine-containing product (TNP) on a daily basis using an electronic diary (eDiary).
Interventions
- OTHER P1213416
- OTHER P1213422
- OTHER P1213716
- OTHER P1213722
- OTHER P1211216
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,845 participants |
| Start Date | 2023-09-15 |
| Est. Completion | 2024-01-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05960305
The ClinicalTrials.gov registry entry for NCT05960305 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,845 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RAI Services Company, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which P1213416 is the first listed.
NCT05960305 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05960305 about?
NCT05960305 is a clinical study titled "CSD201204 An Actual Use Study of P12 Electronic Nicotine Delivery System Among U.S. Adult Smokers". The purpose of this Actual Use Study (AUS) is to investigate how United States (US) adult tobacco consumers 21 to 60 years of age, inclusive, who are regular smokers (≥5 cigarettes/day on at least 20 of the past 30 days) will use the Cartridge-based ENDS investigational products (Study IP) over a 6-...
What is the current status of trial NCT05960305?
This trial is currently completed. It is a NA study. The enrollment target is 1,845 participants. The study started on 2023-09-15. Estimated completion is 2024-01-28.
What interventions are being tested in trial NCT05960305?
The interventions under investigation include: P1213416 (OTHER), P1213422 (OTHER), P1213716 (OTHER), P1213722 (OTHER), P1211216 (OTHER).
Who is sponsoring clinical trial NCT05960305?
This trial is sponsored by RAI Services Company, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.